News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
308,246 Results
Type
Article (16868)
Company Profile (321)
Press Release (291057)
Section
Business (90734)
Career Advice (250)
Deals (15226)
Drug Delivery (47)
Drug Development (54135)
Employer Resources (41)
FDA (6563)
Job Trends (6198)
News (162937)
Policy (12274)
Tag
Academia (1203)
Alliances (26001)
Alzheimer's disease (909)
Approvals (6537)
Artificial intelligence (99)
Bankruptcy (114)
Best Places to Work (5415)
Biotechnology (258)
Breast cancer (130)
Cancer (983)
Cardiovascular disease (76)
Career advice (215)
CAR-T (73)
Cell therapy (223)
Clinical research (43065)
Collaboration (367)
Compensation (139)
COVID-19 (1204)
C-suite (84)
Cystic fibrosis (68)
Data (1070)
Diabetes (97)
Diagnostics (2070)
Earnings (32373)
Events (52792)
Executive appointments (253)
FDA (6980)
Funding (335)
Gene editing (69)
Gene therapy (169)
GLP-1 (352)
Government (1644)
Healthcare (8625)
Infectious disease (1245)
Inflammatory bowel disease (101)
IPO (8200)
Job creations (1085)
Job search strategy (191)
Layoffs (224)
Legal (1718)
Lung cancer (138)
Lymphoma (65)
Manufacturing (102)
Medical device (3815)
Medtech (3817)
Mergers & acquisitions (7162)
Metabolic disorders (277)
Neuroscience (1164)
NextGen Class of 2024 (2449)
Non-profit (1540)
Northern California (1193)
Obesity (153)
Opinion (112)
Parkinson's disease (78)
Patents (75)
People (27671)
Phase I (14986)
Phase II (19939)
Phase III (12904)
Pipeline (396)
Postmarket research (963)
Preclinical (6268)
Radiopharmaceuticals (216)
Rare diseases (208)
Real estate (1784)
Regulatory (9719)
Research institute (1228)
Southern California (1016)
Startups (2223)
United States (9634)
Vaccines (232)
Weight loss (91)
Date
Last 7 days (495)
Last 30 days (1681)
Last 365 days (23743)
2024 (23224)
2023 (25964)
2022 (31956)
2021 (33597)
2020 (28685)
2019 (19988)
2018 (14643)
2017 (16114)
2016 (14281)
2015 (16728)
2014 (11929)
2013 (8784)
2012 (8838)
2011 (8930)
2010 (8394)
Location
Africa (223)
Arizona (69)
Asia (20583)
Australia (3487)
California (2653)
Canada (893)
China (231)
Colorado (105)
Connecticut (118)
Europe (46515)
Florida (311)
Georgia (78)
Illinois (177)
Indiana (82)
Maryland (370)
Massachusetts (2135)
Michigan (65)
Minnesota (120)
New Jersey (678)
New York (739)
North Carolina (453)
Northern California (1193)
Ohio (90)
Pennsylvania (535)
South America (290)
Southern California (1016)
Texas (347)
Washington State (295)
308,246 Results for "aim therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AIM ImmunoTech Announces Cash Conservation Plan
November 27, 2024
·
6 min read
Press Releases
AIM ImmunoTech Participates in Virtual Investor KOL Connect Segment
December 6, 2024
·
1 min read
Press Releases
Eterna Therapeutics Completes Strategic Financial Restructuring with the Aim to Accelerate its Developmental Activities and Long-Term Success
October 30, 2024
·
4 min read
Press Releases
Kellner Group Urges Stockholders of AIM Immunotech to Vote Gold Card
December 13, 2024
·
27 min read
BioMidwest
AIM ImmunoTech to Participate in the Virtual Investor Lunch Break Series
AIM ImmunoTech Inc., announced that Thomas K. Equels, MS JD, Chief Executive Officer of AIM will participate in the Virtual Investor Lunch Break Series on Wednesday, June 5, 2024 at 12:00 PM ET.
June 3, 2024
·
1 min read
BioMidwest
AIM ImmunoTech to Participate in Two Upcoming May 2024 Investor Conferences
AIM ImmunoTech Inc. announced that AIM Chief Executive Officer Thomas K. Equels will participate in two upcoming investor conferences.
May 20, 2024
·
1 min read
Deals
AIM ImmunoTech Announces Pricing of $2.0 Million Registered Direct Offering
AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that it has entered into a securities purchase agreement with a single institutional investor to purchase 5,640,958 shares of common stock in a registered direct offering at a purchase price of $0.363 per share.
May 31, 2024
·
4 min read
BioMidwest
AIM ImmunoTech Completes cGMP Manufacturing of Clinical Vials of Ampligen®
AIM ImmunoTech Inc. announced the successfully completion of cGMP manufacturing of 9,042 clinical vials of Ampligen®, AIM’s dsRNA product candidate being developed for globally important cancers, viral diseases and disorders of the immune system.
May 6, 2024
·
2 min read
AIM ImmunoTech to Participate in the Virtual Investor Lunch Break: The AIM Opportunity
AIM ImmunoTech Inc. today announced that it will present at the Virtual Investor Lunch Break: The AIM Opportunity event on Wednesday, March 20, 2024 at 12:00 PM ET.
March 15, 2024
·
1 min read
Deals
Sarepta Aims Up to $10B at Arrowhead to Diversify Pipeline With RNA Drugs
With Elevidys expansion in hand, Sarepta commits up to $10 billion to develop short interfering RNA–based drugs to build out its pipeline.
November 26, 2024
·
2 min read
·
Kate Goodwin
1 of 30,825
Next
